These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2784066)

  • 1. The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation.
    Pegoraro L; Malavasi F; Bellone G; Massaia M; Boccadoro M; Saglio G; Guerrasio A; Benetton G; Lombardi L; Coda R
    Blood; 1989 Mar; 73(4):1020-7. PubMed ID: 2784066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene.
    Gazdar AF; Oie HK; Kirsch IR; Hollis GF
    Blood; 1986 Jun; 67(6):1542-9. PubMed ID: 2423157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
    Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
    Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
    Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
    Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
    Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
    Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of two human myeloma cell lines secreting kappa light chains.
    Eton O; Scheinberg DA; Houghton AN
    Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of human B cell proliferation and differentiation by the combination of phorbol ester and ionomycin.
    Roifman CM; Benedict SH; Cheung RK; Gelfand EW
    Eur J Immunol; 1987 May; 17(5):701-6. PubMed ID: 3495445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.
    Greil R; Fasching B; Loidl P; Huber H
    Blood; 1991 Jul; 78(1):180-91. PubMed ID: 2070052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line.
    Jernberg-Wiklund H; Pettersson M; Larsson LG; Anton R; Nilsson K
    Int J Cancer; 1992 Apr; 51(1):116-23. PubMed ID: 1563831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocyte function in multiple myeloma: analysis of T cell- and monocyte-dependent antibody production.
    Petersen J; Drivsholm A; Brandt M; Ambjørnsen A; Dickmeiss E
    Eur J Haematol; 1989 Feb; 42(2):193-201. PubMed ID: 2492949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular analysis of multiple myeloma cells].
    Yasuga Y; Hirosawa S
    Nihon Rinsho; 1995 Mar; 53(3):564-7. PubMed ID: 7699886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of c-fos and c-myc mRNA levels in normal human lymphocytes by calcium ionophore A23187 and phorbol ester.
    Grausz JD; Fradelizi D; Dautry F; Monier R; Lehn P
    Eur J Immunol; 1986 Oct; 16(10):1217-21. PubMed ID: 3095123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular oncogenes and lymphocyte activation.
    Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
    Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    Klemsz MJ; Justement LB; Palmer E; Cambier JC
    J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
    Togawa A; Inoue N; Mannoji M; Namba M
    Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features.
    Grogan TM; Durie BG; Lomen C; Spier C; Wirt DP; Nagle R; Wilson GS; Richter L; Vela E; Maxey V
    Blood; 1987 Oct; 70(4):932-42. PubMed ID: 3115338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.